Fluid delivery methods
US-2024408593-A1 · Dec 12, 2024 · US
US2016349252A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016349252-A1 |
| Application number | US-201615167533-A |
| Country | US |
| Kind code | A1 |
| Filing date | May 27, 2016 |
| Priority date | May 29, 2015 |
| Publication date | Dec 1, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A system for determining a level of cotinine in a sample includes a test strip system configured to receive a sample, the test strip system including a first lateral flow test strip and a second lateral flow test strip, the first and second lateral flow test strips each having an overlapping but non-identical range for cotinine. The system further includes a meter configured to receive the test strip, wherein the meter is configured to read the test strip and detect a level of cotinine.
Opening claim text (preview).
What is claimed as new and desired to be protected by Letters Patent of the United States is: 1 . A system for determining a level of cotinine in a sample, comprising: a test strip system configured to receive a sample, the test strip system including a first lateral flow test strip and a second lateral flow test strip, the first and second lateral flow test strips each having an overlapping but non-identical range for cotinine; and a meter configured to receive the test strip, wherein the meter is configured to read the test strip and detect a level of cotinine. 2 . The system of claim 1 , wherein the first and second lateral flow test strips each include microparticles combined with a cotinine antibody. 3 . The system of claim 2 , wherein the first and second lateral flow test strips each include compounds to bind with the microparticles combined with a cotinine antibody. 4 . The system of claim 3 , wherein for the first test strip the microparticles combined with a cotinine antibody include an antibody for cotinine 3 . 5 . The system of claim 3 , wherein for the second test strip the microparticles combined with a cotinine antibody include an antibody for cotinine 4 . 6 . The system of claim 4 , wherein for the second test strip the microparticles combined with a cotinine antibody include an antibody for cotinine 4 , and the combination of the first and second test strips results in a larger testing range for cotinine using the test strip system. 7 . The system of claim 6 , wherein the antibody for cotinine 3 is monoclonal. 8 . The system of claim 6 , wherein the antibody for cotinine 4 is polyclonal. 9 . The system of claim 6 , wherein the test strip system includes a red blood cell separation membrane. 10 . The system of claim 9 , wherein the red blood cell separation membrane is a vertical flow membrane. 11 . The system of claim 10 , wherein the test strip system includes a sample pad oriented in line with an opening in a cartridge, the cartridge holding the sample pad, the red blood cell separation membrane, and the first and second lateral flow test strips. 12 . The system of claim 10 , wherein the test strip system includes a wicking membrane in a cartridge, and the cartridge holding the red blood cell separation membrane and the wicking membrane forms a stack of membranes in that order, the stack of membranes being approximately in vertical alignment with the opening, and the wicking membrane oriented in contact with the first and second lateral flow test strips in order to provide sample to the lateral flow test strips. 13 . A system for determining a level of cotinine in a sample, comprising: a test strip system configured to receive a sample; and a meter configured to receive the test strip, wherein the meter is configured to read the test strip and detect a level of cotinine. 14 . The system of claim 13 , wherein the test strip system includes a red blood cell separation membrane. 15 . The system of claim 14 , wherein the test strip system includes a lateral flow test strip. 16 . The system of claim 15 , wherein the test strip system includes a red blood cell separation membrane. 17 . The system of claim 16 , wherein the red blood cell separation membrane is a vertical flow membrane. 18 . The system of claim 17 , wherein the test strip system includes a wicking membrane in the cartridge. 19 . The system of claim 18 , wherein a cartridge holds the red blood cell separation membrane and the wicking membrane and forms a stack of membranes in that order, the stack of membranes being approximately in vertical alignment with the opening, the wicking membrane oriented in contact with the lateral flow test strip in order to provide sample to the lateral flow test strip. 20 . The system of claim 19 , wherein the lateral flow test strip includes microparticles combined with a cotinine antibody. 21 . The system of claim 20 , wherein the test strip includes a first test site, the first test site including compounds to bind with the microparticles combined with a cotinine antibody. 22 . The system of claim 21 , wherein the microparticles are fluorescent. 23 . The system of claim 21 , wherein the microparticles have reflective properties. 24 . The system of claim 21 , wherein the microparticles have properties that provide for the absorption of light. 25 . The system of claim 24 , wherein the meter measures a level of absorption at the first test site to determine the level of cotinine. 26 . The system of claim 23 , wherein the meter measures a level of reflection at the first test site to determine the level of cotinine. 27 . A method of determining a level of cotinine in a sample comprising: providing a test strip system configured to receive a sample wherein the test strip system includes microparticles combined with a cotinine antibody; providing a meter configured to receive the test strip wherein the meter is configured to read the test strip and detect a level of cotinine; placing a sample on the test strip; laterally flowing the sample of the test strip; and reading the test strip with the meter. 28 . The method of claim 27 , wherein the test strip system includes: a sample pad; and a cartridge, the sample pad oriented in line with an opening in a cartridge, the cartridge holding the sample pad, the red blood cell separation membrane, and the lateral flow test strip. 29 . The method of claim 28 , wherein the test strip system includes a wicking membrane in the cartridge. 30 . The method of claim 29 , wherein the cartridge holding the sample pad, the red blood cell separation membrane, and the wicking membrane forms a stack of membranes in that order, the stack of membranes being approximately in vertical alignment with the opening, the wicking membrane oriented in contact with the lateral flow test strip in order to provide sample to the lateral flow test strip. 31 . The method of claim 27 , further comprising binding at least a portion of cotinine with microparticles combined with the cotinine antibody; and binding at least a portion of the microparticles combined with the cotinine antibody to a first test site; wherein the reading of the test strip includes detecting at the first test site to determine the level of cotinine.
CNS-stimulants, e.g. cocaine, amphetamines · CPC title
the carrier being characterised by its particulate form · CPC title
involving narcotics {or drugs or pharmaceuticals, neurotransmitters or associated receptors} · CPC title
involving monoclonal antibodies {binding reaction mechanisms characterised by the use of monoclonal antibodies (G01N33/5302 - G01N33/576 take precedence)} · CPC title
Analytical elements · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.